CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 139 filers reported holding CARA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $8,043,000 | +105.0% | 440,000 | +120.0% | 2.91% | +167.5% |
Q1 2019 | $3,924,000 | +26.1% | 200,000 | +53.8% | 1.09% | +37.2% |
Q3 2018 | $3,113,000 | -56.0% | 130,000 | -66.2% | 0.79% | -77.5% |
Q1 2017 | $7,080,000 | +60.4% | 385,000 | -18.9% | 3.52% | +35.5% |
Q4 2016 | $4,413,000 | -21.7% | 475,000 | -29.6% | 2.60% | -11.9% |
Q3 2016 | $5,636,000 | +40.3% | 675,000 | -19.2% | 2.95% | +10.0% |
Q2 2016 | $4,016,000 | -24.5% | 835,000 | -2.3% | 2.68% | -19.1% |
Q1 2016 | $5,318,000 | -26.1% | 855,000 | +100.2% | 3.32% | +10.2% |
Q4 2015 | $7,199,000 | +21.4% | 427,000 | +2.9% | 3.01% | +3.2% |
Q3 2015 | $5,930,000 | +43.5% | 415,000 | +22.1% | 2.92% | +77.5% |
Q2 2015 | $4,131,000 | +30.5% | 340,000 | +7.9% | 1.64% | +11.8% |
Q1 2015 | $3,166,000 | +296.7% | 315,000 | +293.8% | 1.47% | +264.8% |
Q4 2014 | $798,000 | – | 80,000 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,647,473 | $24,780,000 | 2.96% |
Chescapmanager LLC | 1,160,392 | $10,861,000 | 2.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,333,000 | $12,477,000 | 1.60% |
Altium Capital Management LP | 193,000 | $1,806,000 | 0.66% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,700,230 | $15,914,000 | 0.44% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 171,423 | $1,605,000 | 0.22% |
Lisanti Capital Growth, LLC | 159,225 | $1,490,000 | 0.20% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,529 | $679,000 | 0.15% |
PINNACLE ASSOCIATES LTD | 705,367 | $6,602,000 | 0.15% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $23,400,000 | 0.13% |